Clinical Trial Update: Doppler Evaluation in RA Patients After Adalimumab. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining Doppler evaluation in rheumatoid arthritis patients after treatment with adalimumab.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Hamed Rezaei | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED